XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Mar 07, 2018 4:05pm EST
XOMA Strengthens Leadership Team with Appointments of Chief Business Officer and General Counsel Jan 08, 2018 7:00am EST
XOMA Announces Multiple New License Agreements for Proprietary Phage Display Libraries Oct 04, 2017 9:15am EDT
XOMA Earns $3 Million Milestone Payment from its License Agreement with Nanotherapeutics Sep 11, 2017 7:00am EDT
XOMA to Present at the Rodman and Renshaw 19th Annual Global Investment Conference Sep 06, 2017 7:00am EDT
XOMA Announces Transformational License Agreements for Gevokizumab and its IL-1 Beta Intellectual Property Portfolio Aug 25, 2017 7:00am EDT
